Novel Approaches to Expanding the Lung Donor Pool: Donation After Cardiac Death and Ex Vivo Conditioning

Clinics in Chest Medicine

Volumn 32, Issue 2, 2011, Pages 233-244

  Cypel, Marcelo ^a   Yeung, Jonathan C ^b   Keshavjee, Shaf ^c  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ex vivo lung perfusion; Lung donation after cardiac death; Lung transplantation; Pharmacologic molecular intervention

Indexed keywords

CADAVER DONOR; CLINICAL EVALUATION; DONOR SELECTION; EX VIVO GENE TRANSFER; EXPERIMENTAL TRANSPLANTATION; HEART DEATH; HUMAN; LUNG FUNCTION TEST; LUNG HEMODYNAMICS; LUNG PERFUSION; LUNG TRANSPLANTATION; MEDICAL ETHICS; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; PHARMACOLOGICAL PROCEDURES; PRIORITY JOURNAL; REVIEW;

DEATH; DONOR SELECTION; HUMANS; LUNG TRANSPLANTATION; ORGAN PRESERVATION; PERFUSION; RESPIRATORY FUNCTION TESTS; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 79954620911     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2011.02.003     Document Type: Review

References (81)

1. Unilateral lung transplantation for pulmonary fibrosis. Toronto lung transplant group. N Engl J Med 1986, 314:1140-1145.
2. Barnieh L., Baxter D., Boiteau P., et al. Benchmarking performance in organ donation programs: dependence on demographics and mortality rates. Can J Anaesth 2006, 53:727-731.
3. Tuttle-Newhall J.E., Krishnan S.M., Levy M.F., et al. Organ donation and utilization in the United States: 1998-2007. Am J Transplant 2009, 9:879-893.
4. Egan T.M., Lambert C.J., Reddick R., et al. A strategy to increase the donor pool: use of cadaver lungs for transplantation. Ann Thorac Surg 1991, 52:1113-1120. [discussion: 1120-1].
5. D'Armini A.M., Roberts C.S., Griffith P.K., et al. When does the lung die? I. Histochemical evidence of pulmonary viability after " death" J Heart Lung Transplant 1994, 13:741-747.
6. Alessandrini F., D'Armini A.M., Roberts C.S., et al. When does the lung die? II. Ultrastructural evidence of pulmonary viability after " death" J Heart Lung Transplant 1994, 13:748-757.
7. Van Raemdonck D.E., Jannis N.C., Rega F.R., et al. Extended preservation of ischemic pulmonary graft by postmortem alveolar expansion. Ann Thorac Surg 1997, 64:801-808.
8. Buchanan S.A., DeLima N.F., Binns O.A., et al. Pulmonary function after non-heart-beating lung donation in a survival model. Ann Thorac Surg 1995, 60:38-44. [discussion: 44-6].
9. Greco R., Cordovilla G., Sanz E., et al. Warm ischemic time tolerance after ventilated non-heart-beating lung donation in piglets. Eur J Cardiothorac Surg 1998, 14:319-325.
10. Van Raemdonck D.E., Jannis N.C., De Leyn P.R., et al. Warm ischemic tolerance in collapsed pulmonary grafts is limited to 1 hour. Ann Surg 1998, 228:788-796.
11. Kuang J.Q., Van Raemdonck D.E., Jannis N.C., et al. Pulmonary cell death in warm ischemic rabbit lung is related to the alveolar oxygen reserve. J Heart Lung Transplant 1998, 17:406-414.
12. Rega F.R., Jannis N.C., Verleden G.M., et al. Should we ventilate or cool the pulmonary graft inside the non-heart-beating donor?. J Heart Lung Transplant 2003, 22:1226-1233.
13. Neyrinck A.P., Van De Wauwer C., Geudens N., et al. Comparative study of donor lung injury in heart-beating versus non-heart-beating donors. Eur J Cardiothorac Surg 2006, 30:628-636.
14. Tremblay L.N., Yamashiro T., DeCampos K.N., et al. Effect of hypotension preceding death on the function of lungs from donors with nonbeating hearts. J Heart Lung Transplant 1996, 15:260-268.
15. Van de Wauwer C., Neyrinck A.P., Geudens N., et al. The mode of death in the non-heart-beating donor has an impact on lung graft quality. Eur J Cardiothorac Surg 2009, 36:919-926.
16. Novitzky D., Wicomb W.N., Rose A.G., et al. Pathophysiology of pulmonary edema following experimental brain death in the chacma baboon. Ann Thorac Surg 1987, 43:288-294.
17. Avlonitis V.S., Fisher A.J., Kirby J.A., et al. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation 2003, 75:1928-1933.
18. De Perrot M., Sekine Y., Fischer S., et al. Interleukin-8 release during ischemia-reperfusion correlates with early graft function in human lung transplantation. J Heart Lung Transplant 2001, 20:175-176.
19. De Perrot M., Sekine Y., Fischer S., et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002, 165:211-215.
20. Fisher A.J., Donnelly S.C., Hirani N., et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 2001, 163:259-265.
21. Kaneda H., Waddell T.K., de Perrot M., et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 2006, 6:544-551.
22. Kang C.H., Anraku M., Cypel M., et al. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis. J Heart Lung Transplant 2010, 30(3):289-298.
23. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc 1997, 29:3770-3772.
24. Takada M., Nadeau K.C., Hancock W.W., et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998, 65:1533-1542.
25. Kusaka M., Pratschke J., Wilhelm M.J., et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000, 69:405-410.
26. Steen S., Sjoberg T., Pierre L., et al. Transplantation of lungs from a non-heart-beating donor. Lancet 2001, 357:825-829.
27. Gamez P., Cordoba M., Ussetti P., et al. Lung transplantation from out-of-hospital non-heart-beating lung donors. one-year experience and results. J Heart Lung Transplant 2005, 24:1098-1102.
28. de Antonio D.G., Marcos R., Laporta R., et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant 2007, 26:529-534.
29. Christie J.D., Carby M., Bag R., et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005, 24:1454-1459.
30. Love R.B., Stringham J.C., Chomiak P.N., et al. Successful lung transplantation using a non-heart-beating donor. J Heart Lung Transplant 1995, 14:s88. [abstract].
31. De Oliveira N.C., Osaki S., Maloney J.D., et al. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg 2010, 139:1306-1315.
32. De Vleeschauwer S., Van Raemdonck D., Vanaudenaerde B., et al. Early outcome after lung transplantation from non-heart-beating donors is comparable to heart-beating donors. J Heart Lung Transplant 2009, 28:380-387.
33. Cypel M., Sato M., Yildirim E., et al. Initial experience with lung donation after cardiocirculatory death in Canada. J Heart Lung Transplant 2009, 28:753-758.
34. Puri V., Scavuzzo M., Guthrie T., et al. Lung transplantation and donation after cardiac death: a single center experience. Ann Thorac Surg 2009, 88:1609-1614. [discussion: 1614-5].
35. Mason D.P., Murthy S.C., Gonzalez-Stawinski G.V., et al. Early experience with lung transplantation using donors after cardiac death. J Heart Lung Transplant 2008, 27:561-563.
36. Mason D.P., Thuita L., Alster J.M., et al. Should lung transplantation be performed using donation after cardiac death? The United States experience. J Thorac Cardiovasc Surg 2008, 136:1061-1066.
37. Snell G.I., Levvey B.J., Oto T., et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant 2008, 8:1282-1289.
38. Erasmus M.E., Verschuuren E.A., Nijkamp D.M., et al. Lung transplantation from nonheparinized category III non-heart-beating donors. A single-centre report. Transplantation 2010, 89:452-457.
39. Fischer S., Matte-Martyn A., De Perrot M., et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001, 121:594-596.
40. Shemie S.D., Baker A.J., Knoll G., et al. National recommendations for donation after cardiocirculatory death in Canada: Donation after cardiocirculatory death in Canada. CMAJ 2006, 175:S1.
41. Hopkinson D.N., Bhabra M.S., Hooper T.L. Pulmonary graft preservation: a worldwide survey of current clinical practi. J Heart Lung Transplant 1998, 17:525-531.
42. Southard J.H., Belzer F.O. Organ preservation. Annu Rev Med 1995, 46:235.
43. Muller C., Hoffmann H., Bittmann I., et al. Hypothermic storage alone in lung preservation for transplantation: a metabolic, light microscopic, and functional analysis after 18 hours of preservation. Transplantation 1997, 63:625-630.
44. Pegg D.E. Organ preservation. Surg Clin North Am 1986, 66:617.
45. Brasile L., Stubenitsky B.M., Kootstra G. Solving the organ shortage: potential strategies and the likelihood of success. ASAIO J 2002, 48:211-215.
46. Brasile L., Stubenitsky B.M., Booster M.H., et al. Overcoming severe renal ischemia: the role of ex vivo warm perfusion. Transplantation 2002, 73:897-901.
47. Brasile L., Buelow R., Stubenitsky B.M., et al. Induction of heme oxygenase-1 in kidneys during ex vivo warm perfusion. Transplantation 2003, 76:1145-1149.
48. Brasile L., Stubenitsky B.M., Booster M.H., et al. The underlying mechanism preserving vascular integrity and during ex vivo warm kidney perfusion. Am J Transplant 2003, 3:647-649.
49. Brasile L., Stubenitsky B.M., Haisch C.E., et al. Repair of damaged organs in vitro. Am J Transplant 2005, 5:300-306.
50. Imber C.J., St Peter S.D., Lopez de Cenarruzabeitia I., et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation 2002, 73:701-709.
51. Carrel A., Lindbergh C.A. The culture of whole organs. Science 1935, 81:621-623.
52. Wang L.S., Yoshikawa K., Miyoshi S., et al. The effect of ischemic time and temperature on lung preservation in a simple ex vivo rabbit model used for functional assessment. J Thorac Cardiovasc Surg 1989, 98:333-342.
53. Wisser W., Oturanlar D., Minich R., et al. Closed circuit perfusion of an isolated rabbit lung. A new model for the evaluation of preservation quality of stored lungs. Eur J Cardiothorac Surg 1993, 7:71-74.
54. Trejo H., Urich D., Pezzulo A., et al. Effect of using several levels of positive end-expiratory pressure over barotrauma's induced lung injury in a model of isolated and perfused rabbit lungs. Invest Clin 2006, 47:49-64.
55. Broccard A.F., Vannay C., Feihl F., et al. Impact of low pulmonary vascular pressure on ventilator-induced lung injury. Crit Care Med 2002, 30:2183-2190.
56. Petak F., Habre W., Hantos Z., et al. Effects of pulmonary vascular pressures and flow on airway and parenchymal mechanics in isolated rat lungs. J Appl Physiol 2002, 92:169-178.
57. Hardesty R.L., Griffith B.P. Autoperfusion of the heart and lungs for preservation during distant procurement. J Thorac Cardiovasc Surg 1987, 93:11-18.
58. Brandes H., Albes J.M., Conzelmann A., et al. Comparison of pulsatile and nonpulsatile perfusion of the lung in an extracorporeal large animal model. Eur Surg Res 2002, 34:321-329.
59. Steen S., Liao Q., Wierup P.N., et al. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg 2003, 76:244-252.
60. Aitchinson J.D., Orr H.E., Flecknell P.A., et al. Functional assessment of non-heart-beating donor lungs: prediction of post-transplant function. Eur J Cardiothorac Surg 2001, 20:187-194.
61. Rega F.R., Vanaudenaerde B.M., Wuyts W.A., et al. IL-1beta in bronchial lavage fluid is a non-invasive marker that predicts the viability of the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant 2003, 24:20-28.
62. Rega F.R., Jannis N.C., Verleden G.M., et al. Long-term preservation with interim evaluation of lungs from a non-heart-beating donor after a warm ischemic interval of 90 minutes. Ann Surg 2003, 238:782-792.
63. Egan T.M., Haitchcock J.A., Nicotra W.A., et al. Ex vivo evaluation of human lungs for transplant suitability. Ann Thorac Surg 2006, 81:1205-1213.
64. Snell G.I., Oto T., Levvey B., et al. Evaluation of techniques for lung transplantation following donation after cardiac death. Ann Thorac Surg 2006, 81:2014-2019.
65. Wierup P., Haraldsson A., Nilsson F., et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg 2006, 81:460-466.
66. Erasmus M.E., Fernhout M.H., Elstrodt J.M., et al. Normothermic ex vivo lung perfusion of non-heart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation. Transpl Int 2006, 19:589-593.
67. Cypel M., Yeung J.C., Hirayama S., et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008, 27:1319-1325.
68. Cypel M., Rubacha M., Yeung J., et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009, 9:2262-2269.
69. Sakuma T., Gu X., Wang Z., et al. Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine. Crit Care Med 2006, 34:676-681.
70. Frank J.A., Briot R., Lee J.W., et al. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am J Physiol Lung Cell Mol Physiol 2007, 293:L52-L59.
71. Ware L.B., Wang Y., Fang X., et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 2002, 360:619-620.
72. Inci I., Zhai W., Arni S., et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant 2007, 26:1054-1060.
73. Inci I., Ampollini L., Arni S., et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant 2008, 27:1229-1236.
74. Karamanou D.M., Perry J., Walden H.R., et al. The effect of ex-vivo perfusion on the microbiological profile of the donor lung. J Heart Lung Transplant 2010, 29(Suppl 2):S88.
75. Ritter T., Kupiec-Weglinski J.W. Gene therapy for the prevention of ischemia/reperfusion injury in organ transplantation. Curr Gene Ther 2005, 5(1):101-109.
76. Cassivi S.D., Cardella J.A., Fischer S., et al. Transtracheal gene transfection of donor lungs prior to organ procurement increases transgene levels at reperfusion and following transplantation. J Heart Lung Transplant 1999, 18:1181-1188.
77. Chapelier A., Danel C., Mazmanian M., et al. Gene therapy in lung transplantation: feasibility of ex vivo adenovirus-mediated gene transfer to the graft. Hum Gene Ther 1996, 7:1837-1845.
78. Pellegrini C., O'Brien T., Jeppsson A., et al. Influence of temperature on adenovirus-mediated gene transfer. Eur J Cardiothorac Surg 1998, 13:599-603.
79. Ingemansson R., Eyjolfsson A., Mared L., et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 2009, 87:255-260.
80. Lindstedt S., Hlebowicz J., Koul B., et al. Comparative outcome of double lung transplantation using conventional donor lungs and non-acceptable donor lungs reconditioned ex vivo. Interact Cardiovasc Thorac Surg 2011, 12(2):162-165.
81. Cypel M., Yeung J.C., de Perrot M., et al. Ex vivo lung perfusion in clinical lung transplantation-the " Help" trial. J Heart Lung Transplant 2010, 29:s88.